These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17668502)

  • 1. Consider informed consent policy for treating bisphosphonate patients.
    Bittinger A
    Todays FDA; 2007 Jan; 19(1):9-10. PubMed ID: 17668502
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonate-related osteonecrosis of the jaw in cancer patients and hyperbaric oxygen therapy.
    Erkan M; Bilgi O; Mutluoğlu M; Uzun G
    JOP; 2009 Sep; 10(5):579-80; author reply 581-2. PubMed ID: 19734644
    [No Abstract]   [Full Text] [Related]  

  • 3. Bisphosphonate related osteonecrosis of the jaws: a review and update.
    Weeda L
    J Tenn Dent Assoc; 2009; 89(2):16-9; quiz 20-1. PubMed ID: 19630246
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
    Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
    J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management.
    Ruggiero SL; Mehrotra B
    Annu Rev Med; 2009; 60():85-96. PubMed ID: 18928335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment protocols of bisphosphonate-related osteonecrosis of the jaws.
    Kyrgidis A; Koloutsos G; Vahtsevanos K
    Head Neck; 2009 Aug; 31(8):1112-3; author reply 1113-4. PubMed ID: 19572289
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonate osteonecrosis: a protocol for surgical management.
    Markose G; Mackenzie FR; Currie WJ; Hislop WS
    Br J Oral Maxillofac Surg; 2009 Jun; 47(4):294-7. PubMed ID: 19231046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of bisphosphonate-induced osteonecrosis of the jaw.
    Schilling J
    Northwest Dent; 2008; 87(3):34-5, 37-8, 40. PubMed ID: 18663869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.
    Bagán J; Blade J; Cozar JM; Constela M; García Sanz R; Gómez Veiga F; Lahuerta JJ; Lluch A; Massuti B; Morote J; San Miguel JF; Solsona E
    Med Oral Patol Oral Cir Bucal; 2007 Aug; 12(4):E336-40. PubMed ID: 17664922
    [No Abstract]   [Full Text] [Related]  

  • 10. Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis.
    Agrillo A; Ungari C; Filiaci F; Priore P; Iannetti G
    J Craniofac Surg; 2007 Sep; 18(5):1071-5. PubMed ID: 17912085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteonecrosis of the jaws during treatment with bisphosphonates: diagnosis and therapy].
    Steiner B; Lenz JH; Gundlach KK; Freund M
    Dtsch Med Wochenschr; 2005 Sep; 130(38):2142-5. PubMed ID: 16172955
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
    Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY
    Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialists play down risk of jaw condition.
    Stassen LF
    J Ir Dent Assoc; 2008; 54(4):153. PubMed ID: 18780680
    [No Abstract]   [Full Text] [Related]  

  • 14. Dental management of patients with a history of bisphosphonate therapy: clinical dilemma.
    Migliorati CA; Hsu CJ; Chopra S; Kaltman SS
    J Calif Dent Assoc; 2008 Oct; 36(10):769-74. PubMed ID: 19044097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-associated osteonecrosis of the jaw. A proposal for conservative treatment.
    Pérez SB; Barrero MV; Hernández MS; Knezevic M; Navarro JM; Millares JR
    Med Oral Patol Oral Cir Bucal; 2008 Dec; 13(12):E770-3. PubMed ID: 19047964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bisphosphonates and osteonecrosis of the jaw].
    Saussez S; Filleul O; Loeb I
    Rev Stomatol Chir Maxillofac; 2008 Dec; 109(6):367-73. PubMed ID: 19013624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE; Umland EM
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
    Diel IJ; Fogelman I; Al-Nawas B; Hoffmeister B; Migliorati C; Gligorov J; Väänänen K; Pylkkänen L; Pecherstorfer M; Aapro MS
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):198-207. PubMed ID: 17855108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.